Dupont Jakob
Insider CIK 1553335 · OMED SVP & Chief Medical Officer · ATRA EVP, Head of R&D · BOLT Director · GOSS Chief Medical Officer · PYXS Director · APGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-08-20 | 2026-08-20 | 46,000 | — | $0 | 46,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-08-20 | 2026-08-20 | 46,000 | — | $0 | 46,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | M Exercise deriv | 2026-06-30 | 2026-07-02 | 35,000 | — | $0 | 357,461 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | M Exercise | 2026-06-30 | 2026-07-02 | 35,000 | $1.60 | $56.0K | 73,741 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 35,000 | $3.06 | $107.1K | 38,741 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-03-24 | 2026-03-25 | 45,867 | — | $0 | 45,867 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 2,500 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 849 | — | $0 | 849 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 1,100 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,000 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 849 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-05-27 | 2025-07-02 | 1,100 | — | $0 | 1,100 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-05-01 | 2025-05-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 36,979 | $0.98 | $36.2K | 36,979 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2024-09-03 | 2024-09-06 | 16,984 | — | $0 | 16,984 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2024-09-03 | 2024-09-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2024-03-26 | 2024-03-28 | 38,741 | — | $0 | 38,741 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-09-22 | 2023-09-26 | 392,461 | — | $0 | 392,461 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-08-23 | 2023-08-25 | 17,250 | — | $0 | 17,250 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-08-23 | 2023-08-25 | 3,534 | — | $0 | 3,534 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-08-23 | 2023-08-25 | 5,879 | — | $0 | 5,879 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 20,489 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-03-02 | 2023-03-06 | 5,074 | $3.63 | $18.4K | 290,794 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2023-03-01 | 2023-03-03 | 317,987 | — | $0 | 317,987 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 141,328 | — | $0 | 295,868 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-11-16 | 2022-11-18 | 1,124 | $4.49 | $5.0K | 154,540 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-11-16 | 2022-11-18 | 3,218 | $4.49 | $14.4K | 155,664 | SEC↗ |
| APGN Apexigen, Inc. | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-08-16 | 2022-08-18 | 4,124 | $5.03 | $20.7K | 158,882 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-05-17 | 2022-05-19 | 3,873 | $5.32 | $20.6K | 163,006 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 147,573 | — | $0 | 147,573 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 78,506 | — | $0 | 169,100 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-03-01 | 2022-03-03 | 2,221 | $9.86 | $21.9K | 166,879 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2022-02-10 | 2022-02-14 | 5,000 | — | $0 | 257,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2022-02-10 | 2022-02-14 | 5,000 | $9.58 | $47.9K | 95,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-02-10 | 2022-02-14 | 5,000 | $16.00 | $80.0K | 90,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 262,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-01-03 | 2022-01-05 | 5,000 | $16.01 | $80.1K | 90,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2022-01-03 | 2022-01-05 | 5,000 | $9.58 | $47.9K | 95,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2021-12-01 | 2021-12-03 | 5,000 | — | $0 | 267,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-12-01 | 2021-12-03 | 5,000 | $17.94 | $89.7K | 90,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2021-12-01 | 2021-12-03 | 5,000 | $9.58 | $47.9K | 95,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-11-16 | 2021-11-18 | 2,199 | $17.12 | $37.6K | 90,594 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2021-11-02 | 2021-11-04 | 5,000 | — | $0 | 272,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2021-11-02 | 2021-11-04 | 5,000 | $9.58 | $47.9K | 97,793 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-11-02 | 2021-11-04 | 5,000 | $16.41 | $82.0K | 92,793 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-08-17 | 2021-08-19 | 2,152 | $12.53 | $27.0K | 92,793 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-05-18 | 2021-05-20 | 5,184 | $14.55 | $75.4K | 94,945 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-03-01 | 2021-03-03 | 81,327 | — | $0 | 81,327 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-03-01 | 2021-03-03 | 53,879 | — | $0 | 100,129 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-05-14 | 2020-05-19 | 277,500 | — | $0 | 277,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-05-14 | 2020-05-19 | 46,250 | — | $0 | 46,250 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 71,500 | — | $0 | 71,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2020-02-14 | 2020-02-19 | 46,500 | — | $0 | 46,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | M Exercise deriv | 2019-12-30 | 2019-12-31 | 40,000 | — | $0 | 439,317 | SEC↗ |
| GOSS Gossamer Bio, Inc. | M Exercise | 2019-12-30 | 2019-12-31 | 40,000 | $10.71 | $428.4K | 40,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2019-12-30 | 2019-12-31 | 40,000 | $15.00 | $600.0K | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | M Exercise deriv | 2019-12-27 | 2019-12-31 | 1,994 | — | $0 | 479,317 | SEC↗ |
| GOSS Gossamer Bio, Inc. | M Exercise | 2019-12-27 | 2019-12-31 | 1,994 | $10.71 | $21.4K | 1,994 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 1,994 | $15.81 | $31.5K | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 65,000 | — | $0 | 65,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 34,440 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2016-01-11 | 2016-01-12 | 2,500 | — | $0 | 138,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2016-01-11 | 2016-01-12 | 2,500 | $4.56 | $11.4K | 23,142 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-11 | 2016-01-12 | 2,500 | $20.01 | $50.0K | 20,642 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 20,642 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 20,712 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.54 | $1.5K | 20,643 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-12-10 | 2015-12-14 | 2,500 | — | $0 | 141,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-12-10 | 2015-12-14 | 2,500 | $4.56 | $11.4K | 25,304 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-12-10 | 2015-12-14 | 2,500 | $20.49 | $51.2K | 22,804 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-11-10 | 2015-11-12 | 2,500 | — | $0 | 143,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-11-10 | 2015-11-12 | 2,500 | $21.17 | $52.9K | 22,804 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-11-10 | 2015-11-12 | 2,500 | $4.56 | $11.4K | 25,304 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-10-26 | 2015-10-27 | 5,000 | — | $0 | 146,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-10-26 | 2015-10-27 | 5,000 | $20.00 | $100.0K | 22,804 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-10-26 | 2015-10-27 | 5,000 | $4.56 | $22.8K | 27,804 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-08-10 | 2015-08-12 | 2,500 | — | $0 | 151,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-08-10 | 2015-08-12 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-08-10 | 2015-08-12 | 2,500 | $22.25 | $55.6K | 22,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-07-10 | 2015-07-13 | 2,500 | — | $0 | 153,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-07-10 | 2015-07-13 | 2,500 | $20.13 | $50.3K | 22,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-07-10 | 2015-07-13 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-07-06 | 2015-07-07 | 2,500 | — | $0 | 156,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-07-06 | 2015-07-07 | 2,500 | $21.22 | $53.0K | 22,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-07-06 | 2015-07-07 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-04-10 | 2015-04-14 | 1,500 | — | $0 | 158,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-10 | 2015-04-14 | 1,500 | $26.51 | $39.8K | 22,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-04-10 | 2015-04-14 | 1,500 | $4.56 | $6.8K | 23,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-03-10 | 2015-03-12 | 1,500 | — | $0 | 160,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-03-10 | 2015-03-12 | 1,500 | $4.56 | $6.8K | 23,120 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-03-10 | 2015-03-12 | 1,500 | $27.17 | $40.8K | 21,620 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-02-10 | 2015-02-12 | 1,500 | — | $0 | 161,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-02-10 | 2015-02-12 | 1,500 | $24.23 | $36.3K | 21,620 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-02-10 | 2015-02-12 | 1,500 | $4.56 | $6.8K | 23,120 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-01-12 | 2015-01-14 | 1,500 | — | $0 | 163,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-01-12 | 2015-01-14 | 400 | $26.62 | $10.6K | 21,620 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-01-12 | 2015-01-14 | 1,100 | $25.63 | $28.2K | 22,020 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-01-12 | 2015-01-14 | 1,500 | $4.56 | $6.8K | 23,120 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-01-05 | 2015-01-07 | 7,500 | — | $0 | 164,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-01-05 | 2015-01-07 | 7,500 | $23.00 | $172.5K | 21,620 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-01-05 | 2015-01-07 | 7,500 | $4.56 | $34.2K | 29,120 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-12-18 | 2014-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-07-23 | 2014-07-25 | 1,500 | — | $0 | 172,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-07-23 | 2014-07-25 | 1,500 | $23.00 | $34.5K | 20,896 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-07-23 | 2014-07-25 | 1,500 | $4.56 | $6.8K | 22,396 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-06-26 | 2014-06-30 | 1,500 | — | $0 | 173,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-06-26 | 2014-06-30 | 1,500 | $4.56 | $6.8K | 22,396 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-26 | 2014-06-30 | 1,500 | $23.00 | $34.5K | 20,896 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 20,000 | — | $0 | 20,896 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-07-17 | 2013-07-19 | 45,000 | — | $0 | 45,000 | SEC↗ |